Pharmaceutical company AbbVie Inc. paid more than $20 million to 191,555 doctors from August 2013 to December 2015 to promote its testosterone replacement therapy AndroGel, according to ProPublica’s Dollars for Doc’s analysis. AndroGel is a top-selling drug for AbbVie. In June, the company – along with other testosterone manufacturers – will face trial in the first of more than 5,500 lawsuits pending in a multidistrict litigation (MDL) alleging testosterone supplement makers aggressively marketed the treatments but failed to warn about cardiovascular risks with use of the hormones. In total, AbbVie paid $94.1 million to 92,095 doctors to promote dozens of its products, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.